A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide In Subjects with Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets with Insulin Therapy

  • Karounos, Dennis (PI)
  • Anderson, James (CoI)
  • Reynolds, L (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/20/03 → 4/30/06